Primus In News
Push for health care: BCD exemption for lifesaving drugs, additional medical seats and more in Budget 2025
01-02-2025
Nilaya Varma, Co-Founder and CEO, Primus Partners, stated that the government's move to reduce customs duties on life-saving drugs is a much-needed measure to help the middle class access critical treatments for life-threatening conditions.
Explore Related Insights
- India needs to reduce China dependence in rare earth magnet for EV sector | Report
- Union Budget 2022-23 to boost Digital India, economy & create job opportunities, say industry, analysts
- Tech growth conclave to see participants of leading global & Indian companies
- Is Carbon Credit Trading Scheme the key to India’s net-zero emissions goal?